deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02163694

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer

Sponsor: AbbVie

Updated 29 times since 2017 Last updated: Feb 18, 2025 Started: Apr 8, 2014 Primary completion: Apr 5, 2019 Completion: Jan 25, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Metastatic Breast Cancer, this trial is completed. The trial is conducted by AbbVie and has accumulated 29 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Sep 2017 · 4 months · monthly snapshot~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Jan 2019 · 3 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Oct 2019 · 5 months · monthly snapshot~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Sep 2020 · 4 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Feb 2023 · 7 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Mar 2024 · 12 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – present · 9 months · monthly snapshot

Change History

29 versions recorded
  1. Nov 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2025 — Nov 2025 [monthly]

    Completed PHASE3

  3. Mar 2025 — Sep 2025 [monthly]

    Completed PHASE3

  4. Sep 2024 — Mar 2025 [monthly]

    Completed PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

Show 24 earlier versions
  1. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  2. Mar 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2023 — Mar 2023 [monthly]

    Active Not Recruiting PHASE3

  4. Jul 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE3

  5. May 2022 — Jul 2022 [monthly]

    Active Not Recruiting PHASE3

  6. Apr 2022 — May 2022 [monthly]

    Active Not Recruiting PHASE3

  7. Feb 2022 — Apr 2022 [monthly]

    Active Not Recruiting PHASE3

  8. Sep 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE3

  9. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

  10. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  11. May 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE3

  12. Feb 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE3

  13. Oct 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE3

  14. May 2019 — Oct 2019 [monthly]

    Active Not Recruiting PHASE3

  15. Mar 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE3

  16. Jan 2019 — Mar 2019 [monthly]

    Active Not Recruiting PHASE3

  17. Oct 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE3

  18. Jun 2018 — Oct 2018 [monthly]

    Active Not Recruiting PHASE3

  19. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  20. Dec 2017 — Feb 2018 [monthly]

    Recruiting PHASE3

  21. Sep 2017 — Dec 2017 [monthly]

    Recruiting PHASE3

  22. May 2017 — Sep 2017 [monthly]

    Recruiting PHASE3

  23. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE3

  24. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AbbVie
Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .